IFF recasts results after planned Food Ingredients sale to CVC

IFF said it expects to sell its Food Ingredients business to funds advised by CVC Capital Partners by the end of the second quarter of 2027, while retaining an approximately 10% equity interest; the deal remains subject to consultations, regulatory approvals and other closing conditions. Together with the Soy Crush, Concentrates and Lecithin sale completed March 2, 2026, the businesses are now classified as discontinued operations, reducing recast 2025 continuing-operations sales to $7.63 billion and adjusted operating EBITDA to $1.55 billion; first-quarter 2026 recast continuing-operations sales were $1.91 billion, net income was $155 million, and diluted EPS was $0.60.